Scope of the Problem
Centers for Disease Control and Prevention reports that 100 percent of low-income countries are affected by at least five NTDs simultaneously, and these diseases kill an estimated 534,000 people worldwide every year. They are a major cause of disease burden, resulting in approximately 57 million years of life lost due to premature disability and death. World Health Organization reports that 42 million people are affected by lymphatic filariasis, or LF, and approximately 2 billion people are infected with soil-transmitted helminths, or STH, worldwide.
IMA is an implementing partner in the ENVISION project in the Democratic Republic of Congo, Haiti and Tanzania. IMA also addresses morbidity management for NTDs, including Trachoma and Hydrocele, in Tanzania and tackles kala-azar in South Sudan.
In the past year, 3,243,074 individuals were treated for LF and STH; of which 805,092 are school-aged children.
Seventy-four districts, with a population of more than 15 million people, have achieved criteria for stopping mass drug administration for LF. In addition 4 million children were treated for intestinal worms and 90,284 community drug distributors were trained.
IMA conducts annual mass drug administration of three medications among more than 500,000 people in six zones of Maniema Province, with the goal of treating 80 percent of the population. In the past year IMA achieved 98.9 percent coverage for STH.
Visceral leishmaniasis, also known as kala-azar, is a parasitic disease that is almost always fatal if not treated. Through the KalaCORE program, 3,080 people received emergency health education and 91 health workers were trained on diagnosis and management of kala-azar.